Recombinant human erythropoietin therapy in low-birthweight preterm infants: A prospective controlled study

Pediatrics International

Volumn 47, Issue 1, 2005, Pages 67-71

  Arif, Bahar ^a   Ferhan, Karademir ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Anemia; Erythropoietin; Prematurity

Indexed keywords

ALPHA TOCOPHEROL; ERYTHROPOIETIN; FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FERRITIN BLOOD LEVEL; GESTATIONAL AGE; HEMATOCRIT; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; LOW BIRTH WEIGHT; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; TREATMENT OUTCOME;

ANEMIA, NEONATAL; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PROSPECTIVE STUDIES;

EID: 14644425253     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02007.x     Document Type: Article

References (19)

1. Brugnara C, Platt OS. The Neonatal erythrocyte and its disorders. In: Nathan DG, Oski FA (eds). Nathan and Oski's Hematology of Infancy and Childhood, 5th edn. W.B. Saunders, Philadelphia, 1998; 42-6.
2. Shannon KM, Mentzer WC, Abels RI et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J. Pediatr. 1991; 118: 949-55.
3. Christensen RD, Hunter DD, Ohls RK. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony stimulating factor for treatment of the anemia of prematurity. J. Perinatol. 1994; 14: 110-13.
4. Maier RF, Obladen M, Muller-Hansen I et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J. Pediatr. 2002; 141: 8-15.
5. Phibbs RH, Shannon KM, Mentzer WC. Potential for treatment of anemia of prematurity with recombinant human erythropoietin, preliminary results. Acta Hematol. 1992; 87: 28-33.
6. Bechensteen AG, Haga P, Halvorsen S et al. Erythropoietin, protein and iron supplementation and the prevention of anemia of prematurity. Arch. Dis. Child. 1993; 69: 19-23.
7. Beck D, Masserey E, Meyer M, Calame A. Weekly intravenous administration of recombinant human erythropoietin in infants with the anemia of prematurity. Eur. J. Pediatr. 1991; 150: 767-72.
8. Brown MS, Jones MA, Ohls RK, Christensen RD. Single dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration. J. Pediatr. 1993; 122: 655-7.
9. Chen JY, Wu TS, Chanlai SP. Recombinant human erythropoietin in the treatment of anemia of prematurity. Am. J. Perinatol. 1995; 12: 314-18.
10. Emmerson AJ, Coles HJ, Stem CM, Pearson TC. Double blind trial of recombinant human erythropoietin in preterm infants. Arch. Dis. Child. 1993; 68: 291-6.
11. Shannon KM, Keith JF, Mentzer WC et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995; 95: 1-8.
12. Walker M, Hull A. Preterm labor and birth. In: Taeusch HW, Ballard RA (eds). Avery's Diseases of the Newborn, 7th edn. W.B. Saunders, Philadelphia, 1998; 144-53.
13. Shannon KM, Naylor GS, Torkildson JC et al. Circulating erythroid progenitors in the anemia of Prematurity. N. Engl. J. Med. 1987; 317: 728-33.
14. Zachee P. Controversies in selection of epoetin dosages. Issues and answers. Drugs 1995; 49: 536-47.
15. Bridges KR. Iron Metabolism and sideroblastic anemia. In: Nathan DG, Oski FA (eds). Nathan and Oski's Hematology of Infancy and Childhood, 5th edn. W.B. Saunders, Philadelphia, 1998; 391-412.
16. Markham A, Bryson HM. Epoetin alfa. A rewiev of its pharmacodynamic a pharmacokinetic properties and therapeutic use in nonrenal applications. Drugs 1995; 49: 232-54.
17. Imai N, Kawamura A, Higushi M et al. Physicochemical and biological comparison of recombinant human erythropoietin with human urinary erythropoietin. J. Biochem. (Tokyo) 1990; 107: 352-9.
18. Ohls RK. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J. Pediatr. 2002; 141: 3-6.
19. Donato H, Vain N, Rendo P et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomised, placebo-controlled, multicenter trial. Pediatrics 2000; 105: 1066-72.